Multi-omic profiling reveals pericyte and smooth muscle cell contributions to CADASIL pathology in cell-specific

Yazi Huang1, Veronica Clementel1, Mingzi Zhang1

  • 1Department of Physiology and Neuroscience, University of Southern California, Los Angeles, CA 90033, USA; Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

Cell Reports
|April 17, 2026
PubMed

Insights

Researchers investigated how specific cell types contribute to CADASIL, a genetic cause of stroke and dementia. They found that mutations in Notch3 within smooth muscle cells or pericytes lead to distinct brain changes and memory deficits.

Area of Science:

  • Neuroscience
  • Genetics
  • Vascular Biology

Background:

  • Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a primary cause of vascular dementia and stroke.
  • CADASIL arises from mutations in the Notch3 gene, but the specific roles of different cell types in its pathology are unclear.

Purpose of the Study:

  • To elucidate the cell-type-specific contributions of Notch3 mutations in smooth muscle cells (SMCs) and pericytes to CADASIL pathogenesis.
  • To investigate the distinct neurovascular and inflammatory consequences of Notch3 mutations in these mural cell populations.

Main Methods:

  • Generation of conditional knockin mouse models with the CADASIL-associated Notch3R170C mutation specifically in SMCs or pericytes.
  • Analysis of neurovascular changes, neuroinflammation, and memory deficits in mutant mice.
  • Proteomic profiling of brain vessels and integration with single-cell RNA sequencing (RNA-seq) data.

Main Results:

  • Both SMC-Notch3R170C and pericyte-Notch3R170C models exhibited perivascular NOTCH3 accumulation but displayed distinct neurovascular pathologies and memory impairments.
  • Proteomic analysis revealed cell-specific responses, including metabolic dysregulation in pericyte-mutant mice and immune signaling alterations in SMC-mutant mice.
  • Findings suggest potential involvement of brain endothelial cells and highlight distinct mural cell-driven mechanisms in CADASIL.

Conclusions:

  • Mural cell-specific Notch3 mutations drive distinct pathological pathways in CADASIL.
  • Understanding these cell-specific mechanisms is crucial for developing targeted therapies for CADASIL and related small vessel diseases.